Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |